SLC16A1 and neoplasm: These data indicate that treatment with AZD3965, at a dose and schedule that triggers MCT1 blockade in MCT4— Raji xenografts, causes a fall in tCho/water, detectable non-invasively using in vivo 1H MRS, as a result of decreased tumour PCho concentrations.